VEGF-C acts on its receptors VEGFR-2/3; inhibition of VEGFR-3 signaling decreases tumor lymphangiogenesis and sentinel node metastasis in VEGF-C expressing tumors [35,36,37]. Here, FLT4 is linked to neoplasm.